<VariationArchive VariationID="1453069" VariationName="NM_002087.4(GRN):c.39dup (p.Leu14fs)" VariationType="Duplication" Accession="VCV001453069" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1432209" VariationID="1453069">
      <GeneList>
        <Gene Symbol="GRN" FullName="granulin precursor" GeneID="2896" HGNC_ID="HGNC:4601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44345302" stop="44353106" display_start="44345302" display_stop="44353106" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42422490" stop="42430469" display_start="42422490" display_stop="42430469" Strand="+" />
          </Location>
          <OMIM>138945</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002087.4(GRN):c.39dup (p.Leu14fs)</Name>
      <CanonicalSPDI>NC_000017.11:44349200:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44349200" stop="44349201" display_start="44349200" display_stop="44349201" variantLength="1" positionVCF="44349200" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42426568" stop="42426569" display_start="42426568" display_stop="42426569" variantLength="1" positionVCF="42426568" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>L14fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_661" sequenceAccession="LRG_661">
            <Expression>LRG_661:g.9081dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42426571dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42426571dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44349203dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44349203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.9081dup">
            <Expression>NG_007886.1:g.9081dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.4" sequenceAccession="NM_002087" sequenceVersion="4" change="c.39dup" MANESelect="true">
            <Expression>NM_002087.4:c.39dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002078.1" sequenceAccession="NP_002078" sequenceVersion="1" change="p.Leu14fs">
            <Expression>NP_002078.1:p.Leu14fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2143325096" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002087.4(GRN):c.39dup (p.Leu14fs) AND multiple conditions" Accession="RCV002037823" Version="3">
        <ClassifiedConditionList TraitSetID="12962">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3539123">Neuronal ceroid lipofuscinosis 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-11-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-11-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16862116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16950801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22608501</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12962" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
            <Trait ID="17311" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GRN-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 11</ElementValue>
                <XRef ID="MONDO:0013866" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CLN11</ElementValue>
                <XRef Type="MIM" ID="614706" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17426" />
                <XRef ID="17426" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="314629" DB="Orphanet" />
              <XRef ID="79262" DB="Orphanet" />
              <XRef ID="C3539123" DB="MedGen" />
              <XRef ID="MONDO:0013866" DB="MONDO" />
              <XRef Type="MIM" ID="614706" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4250610" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="15145831|MedGen:C3539123;C1843792" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002229194" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16862116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16950801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22608501</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with GRN-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu14Alafs*51) in the GRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42426568_42426569insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539123" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843792" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4250610" TraitType="Disease" MappingType="XRef" MappingValue="C1843792" MappingRef="MedGen">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4250610" TraitType="Disease" MappingType="XRef" MappingValue="C3539123" MappingRef="MedGen">
        <MedGen CUI="C3539123" Name="Neuronal ceroid lipofuscinosis 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

